In-Chul Kim
Corporate Officer/Principal chez KAINOS MEDICINE, INC.
Profil
In-Chul Kim is currently the President & Chief Executive Officer at National OncoVenture.
He is also the Vice Chairman at Kainos Medicine, Inc., the Director at Institut Pasteur Korea Research Foundation, and the Chief Strategic Officer at Kainos Medicine, Inc. Dr. Kim holds a doctorate degree from the University of Illinois.
Postes actifs de In-Chul Kim
| Sociétés | Poste | Début |
|---|---|---|
| KAINOS MEDICINE, INC. | Corporate Officer/Principal | - |
Institut Pasteur Korea Research Foundation
 Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Directeur/Membre du Conseil | - |
| National OncoVenture | Directeur Général | - |
Formation de In-Chul Kim
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KAINOS MEDICINE, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Institut Pasteur Korea Research Foundation
Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Health Technology |
| National OncoVenture |
